Friday - February 13, 2026

Category Archives: Marketing & Sales

Atypical Hemolytic Uremic Syndrome Market: Fast-Growing Therapeutics Outlook by 2034 – DelveInsight | Alexion Pharma, Hoffmann-La Roche, Novartis, NovelMed Therapeutics

The Key Atypical Hemolytic Uremic Syndrome Companies in the market include – Alexion Pharmaceuticals, Hoffmann-La Roche, Novartis, NovelMed Therapeutics, and others.   The Atypical Hemolytic Uremic Syndrome market is expected to surge due to the disease’s increasing prevalence and awareness … Continue reading →

Bronchopulmonary Dysplasia Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Chiesi Farmaceutici S.p.A., AyuVis Research, Airway Therapeutic

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Bronchopulmonary Dysplasia pipeline constitutes 10+ key companies continuously working towards developing 12+ Bronchopulmonary Dysplasia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading →

“SEO Blueprint 2026” Report Reveals Why 58% of Local Service Businesses Remain Invisible to Ready-to-Buy Customers

New report “The 2026 SEO Blueprint” reveals why 58% of local service businesses remain invisible online despite 80% of consumers searching locally every week. Includes case study of AB-M Logistics, which saw 67% increase in new business within 90 days … Continue reading →

Advanced Ovarian Cancer Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Pfizer, Daiichi Sankyo, Astellas Pharma, Jiangsu HengRui, Boehringer Ingelheim, Impact

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Advanced Ovarian Cancer pipeline constitutes 50+ key companies continuously working towards developing 50+ Advanced Ovarian Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading →

Alopecia Areata Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Pfizer, Legacy Healthcare, AnaptysBio, Eli Lilly and Company, Incyte, Novartis

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Alopecia Areata pipeline constitutes 18+ key companies continuously working towards developing 20+ Alopecia Areata treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading →